Michelle Zheng

Chief Strategy Officer Zencore Biologics

Michelle Zheng is Chief Strategy Officer and Senior Vice President of Zencore Biologics, bringing more than 30 years of global biopharmaceutical leadership across North America and Asia. She has held senior roles at Apotex, Pfizer, AbbVie, Omeros, Adello Bio, MabPlex, and Frontier Biotech, progressing from bench scientist to executive leadership, including COO positions. Dr. Zheng has extensive expertise in the development and lifecycle management of antibodies, ADCs, peptides, and small molecules, with deep knowledge of CMC strategy, global regulatory affairs, quality systems, technology transfer, and commercialization. She holds a Ph.D. in Plant Biochemistry from the University of Western Ontario and completed an NSERC/Industry Postdoctoral Fellowship in Canada.

Seminars

Monday 12th October 2026
From Clinical Success to Commercial Launch Readiness: CMC Strategies for ADC BLA Readiness
12:30 pm
  • Building BLA readiness from early clinical development to commercialization
  • Establishing robust process characterization and science-based control strategies
  • Executing successful PPQ, validation, and regulatory inspection readiness
  • Ensuring commercial launch readiness and reliable long-term supply
Michelle Zheng - Speaker at 17th World ADC San Diego Summit